Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Search in:

Advanced search

Expert Review of Clinical Pharmacology Volume 15, 2022 - Issue 5

Submit an article Journal homepage

Open access

4,664

Views

CrossRef citations to date

Altmetric

Review

Current status and prospects of IL-6–targeting therapy

Masashi Narazakia Department of Advanced Clinical and Translational Immunology, Osaka University Graduate School of Medicine, Osaka University, Osaka, Japan;b Department of Respiratory Medicine, Clinical Immunology, Osaka University Graduate School of Medicine, Osaka University, Osaka, Japan;c Department of Immunopathology, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, JapanCorrespondence[email protected]

https://orcid.org/0000-0002-5613-4409 View further author information

Tadamitsu Kishimotod Laboratory of Immune Regulation, World Premier International Immunology Frontier Research Center, Osaka University, Osaka, JapanView further author information

Pages 575-592 | Received 20 Apr 2022, Accepted 27 Jun 2022, Published online: 07 Jul 2022

Cite this article
https://doi.org/10.1080/17512433.2022.2097905
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (2)

E. L. Nasonov & Eugen Feist. (2022) The prospects of interleukin-6 inhibition in rheumatoid arthritis: Olokizumab (novel monoclonal antibodies to IL-6). Rheumatology Science and Practice 60:5, pages 505-518.
Crossref

Hong-Yu Liang, Yuyan Wu, Vicky Yau, Huan-Xin Yin, Scott Lowe, Rachel Bentley, Mubashir Ayaz Ahmed, Wenjing Zhao & Chenyu Sun. (2022) SARS-CoV-2 Variants, Current Vaccines and Therapeutic Implications for COVID-19. Vaccines 10:9, pages 1538.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references